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Objectives. Using a local percutaneous coronary intervention (PCI) data repository, we sought to compare the performance of a
number of local and well-known mortality models with respect to discrimination and calibration.
Background. Accurate risk prediction is important for a number of reasons including physician decision support, quality of care
assessment, and patient education. Current evidence on the value of applying PCI risk models to individual cases drawn from a
diﬀerent population is controversial.
Methods. Data were collected from January 01, 2002 to September 30, 2004 on 5216 consecutive percutaneous coronary inter-
ventions at Brigham and Womens Hospital (Boston, MA). Logistic regression was used to create a local risk model for in-hospital
mortality in these procedures, and a number of statistical methods were used to compare the discrimination and calibration of this
new and old local risk models, as well as the Northern New England Cooperative Group, New York State (1992 and 1997), Uni-
versity of Michigan consortium, American College of Cardiology-National Cardiovascular Data Registry, and The Cleveland Clinic
Foundation risk prediction models. Areas under the ROC (AUC) curves were used to evaluate discrimination, and the Hosmer–
Lemeshow (HL) goodness-of-ﬁt test and calibration curves assessed applicability of the models to individual cases.
Results. Multivariate risk factors included in the newly constructed local model were: age, prior intervention, diabetes, unstable
angina, salvage versus elective procedure, cardiogenic shock, acute myocardial infarction (AMI), and left anterior descending artery
intervention. The area under the ROC curve (AUC) was 0.929 (SE = 0.017), and the p value for the Hosmer–Lemeshow (HL) good-
ness-of-ﬁt was 0.473. This indicates good discrimination and calibration. Bootstrap re-sampling indicated AUC stability. Evaluation
of the external models showed an AUC range from 0.82 to 0.90 indicating good discrimination across all models, but poor calibra-
tion (HL p value 6 0.0001).
Conclusions. Validation of AUC values across all models suggests that certain risk factors have remained important over the last
decade. However, the lack of calibration suggests that small changes in patient populations and data collection methods quickly
reduce the accuracy of patient level estimations over time. Possible solutions to this problem involve either recalibration of models
using local data or development of new local models.
 2005 Elsevier Inc. All rights reserved.
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In the last decade, signiﬁcant emphasis has been
placed on the development of statistical models to
help predict risk in various patient populations. In
addition to providing the basis for quality scorecards
[1,2], these risk proﬁles can be helpful on the proce-
dural level to both patients and physicians. Numer-
ous studies have shown that subjective prediction of
risk tends to be poor at very low and very high
probabilities [3,4]. The use of various statistical meth-
ods can provide an objective estimation of outcome
risk.
There has been conﬂicting literature on whether or
not these models can be used outside of their develop-
ment population. Initial validation is usually based on
patients from a given geography and time frame. These
evaluations are only directly applicable in that respect,
and concerns have been raised about the applicability
of a model when patient demographics change with
geography, clinical practice changes with time, and dis-
ease prevalence changes with both. Some of this con-
cern stems from prior analyses showing deleterious
eﬀects on accuracy by changes in geography and time
[5]. A study comparing the demographics of percutane-
ous coronary intervention (PCI) patients in two regis-
tries collected 12 years apart found signiﬁcant
diﬀerences in age, lesion severity, thrombolytic use,
stent use, and death that highlight how much the char-
acteristics of a population can change with a decade of
medical advances [6].
Continuous evaluation of model performance is
important to ascertain that classiﬁcation performance
does not degrade with time. Some models are re-de-
veloped periodically to adjust for temporal trends [7].
Also important is validation of a model on geo-
graphically or temporally distant populations [8].
Constructing a model using a large numbers of pa-
tient encounters across a wide variety of geographic
areas increases the probability that the model will
be suited for diﬀerent populations, but the only
way to determine the models applicability is to ver-
ify the performance empirically in representative
sample.
In the ﬁeld of cardiology, one of the most widely
studied areas of risk stratiﬁcation has been coronary
angiography. This article seeks to build on prior work
on the applicability of risk models in diﬀerent geogra-
phies and over time. Several prior studies of PCI
risk models have shown good external validation with
respect to both calibration and discrimination [9–13].
Others have shown a loss in either discrimination,
calibration [14], or both [15]. In the present study,
we consider the hypothesis that models exhibit diﬀer-
ences in discrimination and calibration over space and
time.2. Methods
2.1. Data collection
Brigham andWomens Hospital (BWH), BostonMas-
sachusetts has maintained a detailed database of all cases
of PCI since 1997. The dataset is based on the American
College of Cardiology National Data Repository dataset
[16], with a variety of additional, detailed, data elements.
The registry is part of the quality assessment and quality
improvement program of Brigham and Womens Hospi-
tal, and was approved by the hospital Institutional Re-
view Board. All catheterization laboratory procedures
performed are included in the database, and real-time
data acquisition is accomplished through a dedicated
team of trained nurses, physicians, and technologists. A
total of 5216 PCI procedures were recorded between Jan-
uary 01, 2002 and September 30, 2004 on all patients who
underwent PCI at BWH. This dataset serves as the source
for the evaluation of each model in this study.
2.2. Model evaluation
Evaluation of all models was done with v2 and max-
imum log likelihood methods. Discrimination was as-
sessed with the area under the receiver operating
characteristic curve (AUC) [17,18]. Calibration was
evaluated with Hosmer–Lemeshow goodness-of-ﬁt v2-
estimates using deciles [19]. 95% conﬁdence intervals
for these parameters were computed with the non-para-
metric bootstrapping method of STATA [20,21]. These
CIs were reported using the percentile method, or bias
corrected method if the estimation bias was greater than
25% of the standard error [22].
2.3. External validation of risk models
Six external and one local previously described multi-
variate post-PCI in-hospital mortality risk models were
evaluatedusing theBWHdataset: theNorthernNewEng-
land Cooperative Group (NNE 1999) [23], the New York
State (NY 1992 & NY 1997) [24,25], University of Mich-
igan Consortium (MI 2001) [26], the American College
of Cardiology-National Cardiovascular Data Registry
(ACC 2002) [27], the Cleveland Clinic Foundation Mul-
ti-Center (CC 1997) [28], and the Brigham and Womens
Hospital (BWH2001) [29]models. Table 1 shows the inde-
pendent risk variables and corresponding odds ratios for
all multivariate models. Pair-wise comparison of the area
under the ROC curve for each model was performed by
Analyse-It 1.71 (Leeds, England, UK) (see Table 2).
2.4. Local model development
To test the hypothesis that time and space degrade
the accuracy of a risk model, a new local model was
Table 1
Overview of the odds ratios for the variables in each model evaluated
Published NY [23] 1992 NY [24] 1997 CC [27] 1997 NNE [22] 1999 MI [25] 2001 BWH [28] 2001 ACC [26] 2002
Shock 67.6 18.31 12.7 11.5 8.33 8.49
Unstable 24.9 4.154
Salvage 13.38
Emergent 7.71 5.75
Urgent 2.19 1.78
Pre-PCI IABP 2.394 3.91 1.68
Male 0.55
Female 2.45 1.308 1.82
Age(log) ÆCæ 24.87
Age ÆCæ 1.062
Age 50–59 NS 2.61
Age 60–69 NS 3.75
Age 70–79 3.32 2.24 6.44
Age > 75 2.53
Age > 79 3.72 2.65 11.25
Diabetes 1.410 1.41
EF 0.93
LVEF < 50 1.66
LVEF 50–59 2.53
LVEF 40–49 3.32 NS
LVEF < 40 5.16
LVEF 20–40 1.490
LVEF 30–39 NS
LVEF 20–29 2.04
LVEF < 20 3.681
LVEF 10–19 3.43
LVEF < 10 3.93
Hx CHF 2.381 3.01
CHF NYHA3/4 8.14
AMI < 6 h 5.220
AMI 6–24 h 3.672
AMI < 24 h 4.75 2.8 1.31
AMI 1–7 days 2.101
Peri-Op MI 1.83
MI Therapy 1.85
Hx Arrest 3.65
SCAI LC-II 1.64
SCAI LC-III 1.87
SCAI LC-IV 2.11
Left main PCI 6.59
Lesion type C 1.94
Tachycardia 2.77
Unstable angina 1.69
L. Main lesion 2.04
Prox LAD Les. 1.97
# Vessels Dis. 1.32 1.54
Renal failure 3.514 3.04
Cr > 2.0 2.33
Cr > 1.5 5.5
CRI 2.71
COPD 1.33
Thrombus 1.67
Thrombolytics 1.39
Non-Stent Dev. 1.64
PVD 1.775 2.12 1.57
Prior Angio. 0.594
>1 Vessels 1.817
Prior CABG 1.431
Stent use 0.51
Lesion complex 1.63
Deﬁnition details can be found in the respective sources.
M.E. Matheny et al. / Journal of Biomedical Informatics 38 (2005) 367–375 369
Table 2
Summary of the training datasets for the models used in this study
Model Dates Location Sample AUC HL(p) Validation type
NNE [22] 1999 1/1/1994 12/31/1996 NH, ME, MA, VT (7) 15331 0.88 0.09 Bootstrap resampling
NY [23] 1992 1/1/1991 6/30/1991 NY 5827 0.884 NA Subset signiﬁcance
NY [24] 1997 1/1/1991 12/31/1994 NY 62670 0.892 0.11 Subset signiﬁcance
MI [25] 2001 10/1/1999 8/30/2000 Detroit, MI 10796 0.90 0.5 Training/test
ACC [26] 2002 1/1/1998 9/30/2000 National 100253 0.89 0.133 Training/test
BWH [28] 2001 1/1/1997 12/31/1999 Boston, MA 2804 0.86 0.11 Training/test
CC [27] 1997 1/11993 12/31/1994 Cleveland, OH (5) 12985 0.846 NA Bootstrap resampling
Sample, sample size. AUC, area under the receiver operating characteristic. HL(p), Hosmer–Lemeshow p value.
Table 3
Univariate association of factors with in-hospital mortality and registry demographics
Factor % Pts % Deaths OR 95% CI p
Age
<50 11.0 0.2 1.00 Ref.
50–59 21.6 0.4 2.55 0.30–39.9 0.392
60–69 27.8 0.9 5.20 0.68–39.9 0.112
70–79 27.6 1.5 8.91 1.199–66.3 0.033
>79 11.9 4.8 29.3 3.98–215.5 0.001
Gender
Male 70.7 1.4 1.00 Ref.
Female 29.3 1.4 1.02 0.61–1.70 0.952
Diabetes 31.7 1.8 1.58 0.99–2.5 0.058
PVD 9.5 2.4 1.97 1.05-3.69 0.034
COPD 10.6 2.0 1.55 0.81–2.97 0.183
Shock 1.7 37.4 82.0 48.1–139.8 <0.001
Unstable angina 4.9 11.6 15.8 9.7–25.7 <0.001
Urgency
Elective 49.9 0.3 1.00 Ref.
Urgent 37.9 0.9 2.98 1.3–6.9 0.010
Emergent 11.8 5.7 19.6 9.1–42.6 <0.001
Salvage 0.4 45.4 270.3 91–803.2 <0.001
LVEF
>39 91.3 1.1 1.00 Ref.
20–39 7.6 3.6 3.22 1.77–5.84 <0.001
<20 1.1 5.5 5.04 1.53–16.6 0.008
Tachycardia 2.4 13.5 14.5 8–17–25.9 <0.001
Pre-PCI IABP 0.7 19.4 19.3 8.15–45.7 <0.001
AMI 24 h 10.6 5.2 6.1 3.8–9.8 <0.001
Cr > 2.0 mg/dL 5.3 5.0 4.5 2.5–8.3 <0.001
CHF 10.1 4.0 3.9 2.3–6.5 <0.001
Prior PCI 33.8 0.5 0.28 0.14–0.57 <0.001
Prior CABG 1101 1.1 0.76 0.41–1.42 0.385
Lesion risk
Low 66.3 0.5 1.00 Ref.
High 33.7 3.0 5.5 3.24–9.4 <0.001
Intervention
LAD 42.4 1.9 1.87 1.17–3.01 0.010
Disease location
Proximal LAD 47.2 2.2 3.34 1.95–5.72 <0.001
RCA 52.3 1.7 1.69 1.03–2.76 0.036
Diseased vessels
0 9.0 0.4 1.00 Ref.
1 52.6 0.9 2.07 0.49–8.8 0.323
2 25.5 1.9 4.5 1.06–19.1 0.041
3 12.8 3.0 7.3 1.7–31.2 0.008
% Pts, percent of sample population. % Deaths, percent of deaths within the sub-population. OR, odds ratio. 95% CI, 95% conﬁdence interval. p, p
value. PVD, peripheral vascular disease. COPD, chronic obstructive pulmonary disease. LVEF, left ventricular ejection fraction. PCI, percutaneous
coronary intervention. IABP, intra-aortic balloon pump. AMI, acute myocardial infarction. Cr, creatinine. CHF, congestive heart failure. CABG,
coronary artery bypass grafting. LAD, left anterior descending. RCA, right coronary artery.
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evaluate the discrimination and calibration of existing
models. Standard univariate methods were used to gen-
erate odds ratios (ORs) with 95% conﬁdence intervals
(CIs) and p values to select variables that would be in-
cluded in the new model [30]. Additionally, all available
covariates which have been shown to be univariate risk
factors in previous studies were included in the analysis
(Table 3). Backward stepwise logistic regression was
performed using STATA [19]. Variables were ﬁrst
removed using a residual Wald v2 p value of 0.1, and
then considered for inclusion based on a p value of
0.05. Since there was no independent test set, the
evaluation was based on bootstrap resampling with
1000 samples [31].3. Results
3.1. Local multivariate prediction rule development
After full backward stepwise variable selection, the
variables associated with an increased risk included old-
er age, diabetes, unstable angina, salvage procedure, car-
diogenic shock, AMI, and any intervention on the left
anterior descending artery as shown in Table 4. TheTable 4
Multivariate analysis of factors signiﬁcantly associated with in-hospital mor
Factor OR 95%
Prior PCI 0.30 0.12–
Age (years)
60–69 4.41 1.31–
70–79 8.25 2.58–
80+ 21.39 6.76–
Diabetes 1.82 1.02–
Unstable 5.46 2.82–
Salvage 19.25 5.06–
Shock 14.86 7.39–
AMI Present 1.72 1.37–
Any LAD PCI 1.72 0.97–
OR, odds ratio. 95% CI, 95% conﬁdence interval. b, beta coeﬃcient. p, p valu
ﬁt v2 = 7.61; p = 0.473; AUC = 0.929. AMI, acute myocardial infarction. LA
Table 5
Summary of discrimination and calibration performance for each model
Curve Deaths AUC 95% CI
NY 1992 96.7 0.82 0.76–0.88
NY 1997 61.6 0.88 0.81–0.92
CC 1997 78.8 0.88 0.82–0.93
NNE 1999 56.2 0.89 0.84–0.94
MI 2001 61.8 0.86 0.81–0.90
BWH 2001 136.1 0.89 0.84–0.93
ACC 2002 49.9 0.90 0.84–0.95
BWH 2004 70.5 0.93 0.89–0.96
Deaths, estimated deaths. AUC, area under the receiver operating characteris
v2. HL(p), Hosmer–Lemeshow prob > v2 value.AUC was 0.929 revealing excellent discriminatory abil-
ity of the new model, and bootstrap re-sampling the
data to obtain a 95% CI of 0.90–0.96 with an SE of
0.017, indicating a good ability to discriminate with re-
spect to the outcome of death. The model had an ade-
quate goodness of ﬁt (HL v2 = 7.61 with 8 df,
p = 0.473).
3.2. External validation
The external model performances on the BWH data-
set are shown in Table 5. During the study period, there
were 71 observed deaths (1.36%). BWH 2004 very clo-
sely approximated this with 70.5 deaths, NY 1992, CC
1997, and BWH 2001 over predicted, and the remainder
under predicted. The AUC indicates excellent discrimi-
nation across all models, with the worst being the New
York State 1992 model and the best being the new local
model. A summary view of the AUC for all models is
shown in Fig. 1. Of the external models, the best AUC
was obtained by the ACC 2002 model.
Pair-wise AUC comparisons were performed as well,
shown in Table 6, by using the method described by
Hanley and McNeil [32]. Overall, the best discrimination
was obtained by the new local model, which attained
signiﬁcance with respect to every model but ACCtality in the new BWH model
CI b p
0.74 1.20 0.009
14.84 1.48 0.016
26.34 2.11 <0.001
66.97 3.06 <0.001
3.26 0.60 0.042
10.52 1.70 <0.001
73.24 2.96 <0.001
29.87 2.70 <0.001
2.17 0.54 <0.001
3.07 0.54 0.066
e. Constant (intercept) = 7.777; Hosmer and Lemeshow goodness-of-
D, left anterior descending. PCI, percutaneous coronary intervention.
HL v2 95% CI HL(p) 95% CI
31.1 13.9–50.0 <0.001 <0.001–0.003
32.2 16.4–45.5 <0.001 <0.001–0.004
27.8 19.6–38.7 <0.001 <0.001–0.013
45.9 31.9–67.4 <0.001 <0.001–<0.001
30.4 16.7–43.1 <0.001 <0.001–0.011
39.7 23.2–73.3 <0.001 <0.001–0.001
42.0 24.9–63.3 <0.001 <0.001–0.002
7.61 1.5–14.2 0.473 0.073–0.992
tic curve. 95% CI, 95% conﬁdence interval. HL v2, Hosmer–Lemeshow
Fig. 1. AUC for all models. The grey line shows no discrimination.
Table 6
Pair-wise discrimination model comparison
NY 1992 NY 1997 CC 1997 NNE 1999 MI 2001 BWH 2001 ACC 2002
Diﬀ p Diﬀ p Diﬀ p Diﬀ p Diﬀ p Diﬀ p Diﬀ p
NY 1992
NY 1997 0.056 0.007
CC 1997 0.051 0.101 0.004 0.859
NNE 1999 0.062 0.013 0.007 0.712 0.011 0.644
MI 2001 0.041 0.165 0.015 0.485 0.01 0.627 0.022 0.310
BWH 2001 0.066 0.019 0.011 0.602 0.015 0.551 0.004 0.849 0.026 0.287
ACC 2002 0.080 0.002 0.025 0.145 0.03 0.176 0.018 0.254 0.040 0.045 0.014 0.519
BWH 2004 0.105 0.001 0.049 0.007 0.053 0.011 0.043 0.048 0.064 0.003 0.038 0.050 0.024 0.176
Diﬀ, AUC diﬀerence. p, p value of diﬀerence.
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model constructed with the largest training set (ACC
2002), followed by the old local model (BWH 2001). Sig-
niﬁcant diﬀerences were noted between NY 1992 and
every model but MI 2001, as well as between MI 2001
and ACC 2002. This indicates that the NY 1992 model,
and to a lesser extent the MI 2001 model, is the least
discriminatory.
The Hosmer–Lemeshow goodness-of-ﬁt test reveals
poor calibration (p < 0.05) for all the models but the
newly developed one. Calibration for all models was fur-
ther explored by plotting the observed to expected fre-
quency of death for each quintile of every model. Fig.
2B is provided to more clearly show the relationships
for the low risk population. As shown in Fig. 2, the
NY 1992 model underestimated the risk of death for
low scoring patients, and over estimated this risk for
high scoring patients. NY 1997 performed fairly well
for low risk patients, but overestimated the probability
of death for high risk patients. ACC 2002 performedwell under low risk conditions, but signiﬁcantly underes-
timated the probability of death for high risk conditions.
NNE 1999 consistently under predicted deaths, and CC
1997 as well as BWH 2001 consistently overestimated
mortality risk. As expected, BWH 2004 performs well,
but since this is not an independent test sample, this re-
sult should be interpreted with caution.4. Discussion
Interventional cardiology practice has changed signif-
icantly over the last decade. Procedural skill develop-
ment, pharmacology, and device development have all
contributed to the evolution of the ﬁeld, and patient out-
comes have changed over that time period in response to
these advances. There as been a substantial reduction in
risk of death and major adverse cardiac events (MACE)
[33] over the past decade. All of these factors create a
moving target for any risk stratiﬁcation model.
Fig. 2. (A) The observed and expected mortality rates for each quintile of patient risk. Each risk quintile contains approximately 1050 patients. The
diagonal line represents a perfect agreement between observed and expected mortality estimates. (B) Expanded view from 0 to 0.15 of the observed to
expected probability ratios.
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set showed good discrimination. The model with the
worst discrimination was NY 1992, which was to be ex-
pected due to the age of the study, and small sample size
with which the model was developed. The best external
model was the one developed on a national databasewith the most patient records, suggesting that geo-
graphic issues may be related to discrimination.
Although these results are promising, it is important
to note that discrimination is not the only (and possibly
not the most important) factor in determining the appli-
cability of a prognostic model from the perspective of
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crimination but still be useless for application on indi-
vidual cases. Good calibration is essential for this type
of application. All models, except possibly the one
developed locally with recent data, but including a mod-
el derived locally, showed poor calibration for our test
set, suggesting that time may play an important role in
the applicability of a model.
Similar ﬁndings have been previously reported. Some
techniques have been suggested to recalibrate the model
[34]. One of these techniques was employed by Kizer et
al. [14] and Peterson et al. [35] with some success, and
may oﬀer a strategy to maintain discrimination and im-
prove calibration.
This study supports routine evaluation of any risk
model, including aging local models, prior to local
implementation. Discrimination was maintained for
most risk adjustment models, though those more re-
cently published and those based on the largest original
datasets appeared to have the most robust discrimina-
tion when applied to a current clinical dataset. The pres-
ervation of discrimination supports the use of these
models for generic risk stratiﬁcation, but the poor cali-
bration indicates that they are not useful for application
in individual cases: the estimated risk of death for a sin-
gle patient that is produced by these models is incorrect.
The poor calibration of the prior models suggests
that variations in practice and patient demographics as
well as clinical features over time have a large eﬀect at
the patient level on the risk estimates accuracy. Further
study is required to identify the optimum frequency of
model recalibration.
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